Should lymphangioleiomyomatosis patients be permitted to donate blood?
Blood Services Section, National Institutes of Health, Clinical Center, Department Transfusion Medicine (CC/DTM), Bethesda, MD, USA.
Anne F
AF
Eder
Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.
Jay H
JH
Ryu
Cardiovascular and Pulmonary Branch, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, USA mossj@nhlbi.nih.gov.
Joel
J
Moss
D000328:Adult; D001782:Blood Donors; D046148:Donor Selection / Q000379:methods / Q000592:standards; D005260:Female; D006801:Humans; D018192:Lymphangioleiomyomatosis / Q000175:diagnosis / Q000473:pathology; D008297:Male; D020380:Needs Assessment; D009367:Neoplasm Staging; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D065227:Transfusion Reaction / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D014481:United States